Alar Pharmaceuticals, Inc. engages in the development of long-acting release drug products for CNS disorders and chronic diseases. It develops drugs for opioid use disorder, chronic pain, and major depressive disorder. The company was founded on September 23, 2016 and is headquartered in Taichung, Taiwan.